FOX04-DRI (Proxofim) – 10mg

FOX04-DRI, also known as Proxofim, is a synthetic D-retro-inverso peptide engineered to disrupt the interaction between FOXO4 and p53. Mechanistic research published under PMID: 28151554 highlights its relevance in studying cellular senescence regulation, transcription factor signaling, and stress-response biochemical pathways.

In controlled laboratory environments, FOX04-DRI is used to analyze protein–protein interaction disruption, peptide-mediated transcriptional modulation, and senescence-associated intracellular dynamics. The D-retro-inverso configuration provides enhanced structural stability in vitro, making FOX04-DRI a valuable tool for senescence-modeling assays, p53 localization research, FOXO family signaling exploration, and biochemical modeling of targeted peptide antagonism.

Its structural specificity supports reproducible application in targeted pathway mapping and protein-interaction profiling. FOX04-DRI is supplied as a high-purity lyophilized peptide intended solely for laboratory use requiring controlled peptide exposure, mechanistic pathway analysis, and reliable biochemical research conditions.

Important Information About This Research Product:

• Your vials are not empty — the lyophilized material collects at the bottom.
• All products arrive as lyophilized powder requiring reconstitution.
• Bacteriostatic water is not supplied.
• Store in a cool, dry environment — short-term at 4°C, long-term at −20°C.
• This material is strictly for laboratory research use only. No instructions for reconstitution, dosing, or administration can be provided.